Avances en la inmunosupresión del trasplante pulmonar

Mcneil, 2008, Evidence for inmunosupresion in lung transplantation, Curr Opin Organ Transplant, 13, 477, 10.1097/MOT.0b013e32831040bf Bhorade, 2009, Immunosupresion for lung transplantation, Proc Am Thorac Soc, 6, 47, 10.1513/pats.200808-096GO Brock, 2001, Induction teherapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thimocyte globulin and daclizumab, J Heart Lung Transplant, 20, 1282, 10.1016/S1053-2498(01)00356-4 Hachem, 2005, A comparation of basiliximab and anti-thimocyte gobulin as induction agents after lung transplantation, J Heart Lung Transplant, 24, 1320, 10.1016/j.healun.2004.09.002 Borro, 2005, Comparative study of basiliximb in lung transplantation, Transplant Proc, 37, 3996, 10.1016/j.transproceed.2005.09.192 Christie, 2011, The registry of the international society for heart and lung transplantation: Twenty-eighth adult lung and heart-lung transplant report 2011, J Heart Lung Transplant, 30, 1104, 10.1016/j.healun.2011.08.004 McCurry, 2005, Early outcomes in human lung transplantation with thymoglobulin or campath-1H for recipient pretreatment followed by postransplant tacrolimus near monoterapy, J Thorac Cardiovasc Surg, 130, 528, 10.1016/j.jtcvs.2004.09.040 Van Loenhout, 2010, Early outcomes using alentuzumab induction in lung transplantation- Interact Cardiovasc Thorac Surg, 10, 190, 10.1510/icvts.2009.213892 Shyu, 2011, Five years outcomes with alemtuzumab induction after lung transpantation, J Heart Lung Transplant, 30, 743, 10.1016/j.healun.2011.01.714 Hachem, 2007, A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation, J Heart Lung Transplant, 26, 1012, 10.1016/j.healun.2007.07.027 Zuckermann, 2003, Cyclosporine A versus tacrolimus in combination with MMF and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial, J Thor Cardiovasc Surg, 125, 891, 10.1067/mtc.2003.71 Borro, 2007, Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome, Transplant Proc, 39, 2416, 10.1016/j.transproceed.2007.06.071 Treede, 2010, Risk of bronchiolitis obliterans syndrome is twice as high in cyclosporine treated patients in comparison to tacrolimus 3 years after lung transplantation: results of a prospective randomized international trial of 248 patients, J Heart Lung Transplant, 29, S39, 10.1016/j.healun.2009.11.107 Sancho, 2011, Conversion of stable cystic fibrosis (CF) lung transplant recipients from a twice-dailyprograf-based regimen to a once-daily modified release tacrolimus-based regimen:preliminary results of the FQ-UST-01 trial, Transpl Int, 24, 113 Mendez, 2012, Pharmacokinetic Study of the Conversion from Tacrolimus to Tacrolimus Retard in Stable Lung Transplantation, J Heart Lung Transplant, 31, S101, 10.1016/j.healun.2012.01.288 Alloway, 2011, Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations, J Heart Lung Transplant, 30, 1003, 10.1016/j.healun.2011.02.008 Van de Plas, 2009, A pilot study on sublingual administration of tacrolimus, Transpl Int, 22, 358, 10.1111/j.1432-2277.2008.00779.x King-Biggs, 2003, Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation, Transplantation, 75, 1437, 10.1097/01.TP.0000064083.02120.2C Bhorade, 2011, Comparison of Sirolimus to Azathioprine in a Tacrolimus based immunosuppressive Regimen in Lung Transplantation, Am J Respir Crit Care Med, 183, 379, 10.1164/rccm.201005-0775OC Snell, 2002, Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment, J Heart Lung Transplant, 21, 540, 10.1016/S1053-2498(01)00421-1 Salgo, 2010, Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-) malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded controlled clinical trial, Am J Transplant, 10, 1385, 10.1111/j.1600-6143.2009.02997.x Iacono, 2006, A randomized trial of inhaled cyclosporine in lung-transplant recipients, N Engl J Med, 354, 141, 10.1056/NEJMoa043204 Whitford, 2002, Addition ofinhaled corticosteroids to systemic immunosuppressionafter lung transplantation: a double-blind, placebo-controlled trial, Transplantation, 73, 1793, 10.1097/00007890-200206150-00016 Johnson, 2003, Statin use is associated with improved function and survival of lung allografts, Am J Respir Crit Care Med, 167, 1271, 10.1164/rccm.200205-410OC Vos, 2011, A randomized placebo-controlled trial of azithromycinto prevent bronchiolitis obliterans syndrome alter lung transplantation, Eur Respir J, 37, 164, 10.1183/09031936.00068310 Martinu, 2011, Acute allograft rejection: Cellular and humoral processes, Clin Chest Medi, 32, 295, 10.1016/j.ccm.2011.02.008 Glanville, 2010, Antibody-mediated rejection in lung transplantation: myth or reality?, J Heart Lung Transplant, 29, 395, 10.1016/j.healun.2010.01.012 Hachem, 2010, Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation, J Heart Lung Transplant, 29, 973, 10.1016/j.healun.2010.05.006 Marques, 2011, Update on extracorporeal photopheresis in heart and lung transplantation, J Clin Apher, 26, 146, 10.1002/jca.20274 Benden, 2008, Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience, Transplantation, 86, 1625, 10.1097/TP.0b013e31818bc024 Morrell, 2010, The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation, J Heart Lung Transplant, 29, 424, 10.1016/j.healun.2009.08.029 Uber, 2009, Generic Drug Immunosuppression in Thoracic Transplantation: An ISHLT Educational Advisory, J Heart Lung Transplant, 28, 655, 10.1016/j.healun.2009.05.001